Reply to Huang et. al. [JHEPAT-D-19-00400R1]

In this issue of the Journal of Hepatology, Huang and colleagues report the successful treatment of 105 Asian patients on hemodialysis using 12 weeks of sofosbuvir/velpatasvir in whom 9 randomly selected patients had serum levels of the predominant sofosbuvir metabolite GS-331007 measured at weeks 4, 8 and 12 of treatment and weeks 4, 12 and 52 post treatment.
Source: Journal of Hepatology - Category: Gastroenterology Authors: Tags: Letter to the Editor Source Type: research